Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 993.85
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 30-Sep-2025
NAV [Rs.]
: 21.9806
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -3.79 | -1.62 | -2.37 | 1.86 | -7.38 | 18.82 | - | 10.47 |
| Category Avg | -1.81 | 3.08 | 0.04 | 10.25 | 0.15 | 18.45 | 20.59 | 13.95 |
| Category Best | 5.06 | 20.4 | 33.34 | 44.6 | 56.39 | 54.56 | 43.04 | 276.41 |
| Category Worst | -5.08 | -4.35 | -13.32 | -7.87 | -21.36 | 6.65 | 5.28 | -25.17 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 21.98 | 1369983 | 218.44 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 11.43 | 714745 | 113.60 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 9.95 | 161295 | 98.89 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 9.81 | 773538 | 97.47 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 5.86 | 307280 | 58.22 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 4.76 | 132849 | 47.29 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 4.29 | 497305 | 42.61 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.70 | 191244 | 36.79 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 3.68 | 355372 | 36.52 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.66 | 68493 | 36.32 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.57 | 143676 | 35.50 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 3.13 | 317139 | 31.11 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 2.68 | 763215 | 26.58 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.46 | 176649 | 24.45 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.09 | 6594 | 20.75 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.90 | 101100 | 18.92 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 1.78 | 102832 | 17.73 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.34 | 53773 | 13.32 |
| Equity | Natco Pharma | Pharmaceuticals & Biotechnology | 0.99 | 113782 | 9.80 |
| Equity | Granules India | Pharmaceuticals & Biotechnology | 0.91 | 184239 | 9.06 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 0.43 | 0 | 4.30 |
| Cash & Cash Equivalent | C C I | -/- | 0.00 | 0 | 0.01 |
| Net CA & Others | Net CA & Others | -/- | -0.40 | 0 | -3.93 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
6,17,875.24
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
